Zobrazeno 1 - 10
of 354
pro vyhledávání: '"S. Shak"'
Autor:
S. Shakthi
Publikováno v:
South Asia Multidisciplinary Academic Journal, Vol 23 (2020)
Supporters of Aadhaar, the unique identification scheme that aims to use biometric information and a 12-digit number to catalogue every Indian resident, have often commented on the tremendous amount of “fraud” that this program has curtailed sinc
Externí odkaz:
https://doaj.org/article/63141e8303db46f587494b57b65f0ac1
Autor:
Silvia Masiero, S. Shakthi
Publikováno v:
South Asia Multidisciplinary Academic Journal, Vol 23 (2020)
Externí odkaz:
https://doaj.org/article/63521090304740f9b4163e2341a7f0f8
Publikováno v:
Cancer Research. 81:GS4-10
Background: The 21-gene recurrence score (RS) provides prognostic information for distant recurrence (DR) and predictive information for chemotherapy (CT) benefit in early breast cancer, whereas clinicopathologic features provide only prognostic info
Autor:
EP Winer, S Shak, KS Albain, Gabriel N. Hortobagyi, GW Sledge, Valentina I. Petkov, Norman Wolmark, Debbie M Jakubowski, Eleftherios P. Mamounas
Publikováno v:
Cancer Research. 79:P3-11
Introduction: The 21-gene Breast Recurrence Score® (RS) in the randomized NSABP B-20, SWOG S8814, and TAILORx studies predicted chemotherapy (CT) benefit for pts with N0 and N+ disease. Endocrine therapy was not inferior to chemoendocrine therapy in
Publikováno v:
Majallah-i ̒Ulum-i Bāghbānī, Vol 38, Iss 2, Pp 353-366 (2024)
Introduction The use of medicinal plants has surged in recent times, with a substantial portion of modern medicines derived from botanical sources. This surge in demand underscores the potential of cultivating and producing medicinal plants to not on
Externí odkaz:
https://doaj.org/article/27c09f8c94ff466ebe594ac26224ed96
Autor:
Rachel Wuerstlein, Hans Kreipe, Benno Nuding, Michael J. Clemens, S Shak, Friedrich Feuerhake, Matthias Christgen, Oleg Gluz, Fred Heinisch, Ronald E. Kates, T. Reimer, Monika Graeser, Cornelia Kolberg-Liedtke, Ulrike Nitz, Nadia Harbeck, Wolfram Malter
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2020)
Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2020)
Background The presence of tumor-infiltrating lymphocytes has been associated with prognosis and chemotherapy response, particularly in high-risk breast cancer subtypes. There is limited data so far as to (i) how tumor-infiltrating lymphocyte (TIL) m
Autor:
Matthias Christgen, Toralf Reimer, H.H. Kreipe, A Pollmanns, A. Stefek, Rachel Wuerstlein, O Gluz, C Chao, Benno Nuding, S Shak, Michael R. Clemens, Wolfram Malter, U. Nitz, Doris Augustin, R Kates, Nadia Harbeck, F Lorenz-Salehi, Christoph Uleer
Publikováno v:
Cancer Research. 78:P1-06
Background: Elderly breast cancer (BC) patients (pts) have been reported to have worse BC-related outcome than younger pts, even within clinical trials such as TEAM. Shak et al. recently showed in a large SEER data analysis that in the high 21-gene r
Publikováno v:
Cancer Research. 77:P6-09
Evaluating the merits of a genomic assay includes measuring analytic and clinical validity, and establishing clinical utility—a property that is not consistently defined. One definition of clinical utility that has gained traction is “the balance
Autor:
Matthias Christgen, Michael Hauptmann, O Gluz, Rick Baehner, Hans Kreipe, Monika Graeser, Jochem Potenberg, Kerstin Luedtke-Heckenkamp, S Shak, Bahriye Aktas, Ronald E. Kates, Nadia Harbeck, Helmut Forstbauer, Michael Braun, Ulrike Nitz, Sherko Kuemmel, Eva-Maria Grischke, Christoph Uleer, Raquel von Schumann, Rachel Wuerstlein, Claudia Schumacher, Maren Darsow
Publikováno v:
Cancer Research. 81:GS4-03
Background: Pathological complete response (pCR) is associated with improved outcome in patients with high-risk HR+/HER2- breast cancer (BC) but the use of (neo)adjuvant chemotherapy in early HR+/HER2- BC remains controversial. Oncotype DX / Recurren
Autor:
Ana Lluch, Priyanka Sharma, Daniel F. Hayes, Jean-Marc Ferrero, Suzette Delaloge, Lajos Pusztai, Lori J. Goldstein, Miguel Martín, Emilio Alba, S Shak, Subkhbinder Dhesy-Thind, Manuel Ramos Vasquez, Stephen Chia, Gabriel N. Hortobagyi, Edith A. Perez, Funda Meric-Bernstam, Claudia Arce-Salinas, Julie R. Gralow, Nancy Lin, Kyung Hae Jung, Anne F. Schott, In Hae Park, William E. Barlow, Kevin Kalinsky, Danika L. Lew, Jieling Miao, Jean-Yves Pierga, Kathy S. Albain, Priya Rastogi, Debu Tripathy, Miguel Gil, Manuel Ruiz Borrego, Etienne Brain
Publikováno v:
Cancer Research. 81:GS3-00
Funding: Supported by National Cancer Institute grants U10CA180888, U10CA180819, U10CA180820, U10CA180821, U10CA180868, U10CA180863; and in part by Susan G. Komen for the Cure® Research Program, The Hope Foundation for Cancer Research, Breast Cancer